Literature DB >> 22287798

Multiple Determinants of Specific Modes of Prescription Opioid Diversion.

Theodore J Cicero, Steven P Kurtz, Hilary L Surratt, Gladys E Ibanez, Matthew S Ellis, Maria A Levi-Minzi, James A Inciardi.   

Abstract

Numerous national surveys and surveillance programs have shown a substantial rise in the abuse of prescription opioids over the past 15 years. Accessibility of these drugs to non-patients is the result of their unlawful channeling from legal sources to the illicit marketplace (diversion). Empirical data on diversion remain absent from the literature. This paper examines abusers' sources of diverted drugs from two large studies: 1) a national sample of opioid treatment clients (N=1983), and 2) a South Florida study targeting diverse populations of opioid abusers (N=782). The most common sources of diverted medications were dealers, sharing/trading, legitimate medical practice (e.g., unknowing medical providers), illegitimate medical practice (e.g., pill mills), and theft, in that order. Sources varied by users' age, gender, ethnicity, risk-aversiveness, primary opioid of abuse, injection drug use, physical health, drug dependence, and either access to health insurance or relative financial wealth. Implications for prescription drug control policy are discussed.

Entities:  

Year:  2011        PMID: 22287798      PMCID: PMC3265104          DOI: 10.1177/002204261104100207

Source DB:  PubMed          Journal:  J Drug Issues        ISSN: 0022-0426


  34 in total

1.  Substance abuse among physicians.

Authors:  E Weir
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

2.  Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential.

Authors:  L Simoni-Wastila; C Tompkins
Journal:  Subst Use Misuse       Date:  2001 Jul-Aug       Impact factor: 2.164

3.  Effects of positive affect on risk perceptions in adolescence and young adulthood.

Authors:  Claudia M Haase; Rainer K Silbereisen
Journal:  J Adolesc       Date:  2010-04-20

4.  FDA approvals of generic drugs: impact on the diversion of opioid analgesics with a potential for abuse.

Authors:  James A Inciardi; Hilary L Surratt; Yamilka Stivers; Theodore J Cicero
Journal:  J Opioid Manag       Date:  2009 Mar-Apr

5.  Determinants of fentanyl and other potent µ opioid agonist misuse in opioid-dependent individuals.

Authors:  Theodore J Cicero; Matthew S Ellis; Alethea Paradis; Zachary Ortbal
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-10       Impact factor: 2.890

Review 6.  An overview of prescription drug misuse and abuse: defining the problem and seeking solutions.

Authors:  B B Wilford; J Finch; D J Czechowicz; D Warren
Journal:  J Law Med Ethics       Date:  1994       Impact factor: 1.718

7.  The use, misuse and diversion of prescription stimulants among middle and high school students.

Authors:  Sean Esteban McCabe; Christian J Teter; Carol J Boyd
Journal:  Subst Use Misuse       Date:  2004-06       Impact factor: 2.164

8.  Use of prescription forgeries in a drug abuse surveillance network.

Authors:  U Bergman; M L Dahl-Puustinen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia.

Authors:  Leonard J Paulozzi; Joseph E Logan; Aron J Hall; Edna McKinstry; James A Kaplan; Alexander E Crosby
Journal:  Addiction       Date:  2009-09       Impact factor: 6.526

10.  Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids.

Authors:  Beth Sproule; Bruna Brands; Selina Li; Laura Catz-Biro
Journal:  Can Fam Physician       Date:  2009-01       Impact factor: 3.275

View more
  32 in total

1.  Patterns of prescription medication diversion among drug dealers.

Authors:  Khary K Rigg; Steven P Kurtz; Hilary L Surratt
Journal:  Drugs (Abingdon Engl)       Date:  2012

2.  Heroin use onset among nonmedical prescription opioid users in the club scene.

Authors:  Hilary L Surratt; Steven P Kurtz; Mance Buttram; Maria A Levi-Minzi; Maria E Pagano; Theodore J Cicero
Journal:  Drug Alcohol Depend       Date:  2017-07-26       Impact factor: 4.492

3.  Patterns of prescription opioid abuse and comorbidity in an aging treatment population.

Authors:  Theodore J Cicero; Hilary L Surratt; Steven Kurtz; M S Ellis; James A Inciardi
Journal:  J Subst Abuse Treat       Date:  2011-08-09

4.  Use of the Internet to Obtain Drugs without a Prescription Among Treatment-involved Adolescents and Young Adults.

Authors:  David S Festinger; Karen L Dugosh; Nicolle Clements; Anna B Flynn; Mathea Falco; A Thomas McLellan; Amelia M Arria
Journal:  J Child Adolesc Subst Abuse       Date:  2016-05-26

5.  Opioid Prescriptions in Older Medicare Beneficiaries After the 2014 Federal Rescheduling of Hydrocodone Products.

Authors:  Yong-Fang Kuo; Mukaila A Raji; Victor Liaw; Jacques Baillargeon; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2018-04-14       Impact factor: 5.562

Review 6.  Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain.

Authors:  Esad Ulker; Egidio Del Fabbro
Journal:  Oncologist       Date:  2019-12-24

7.  Developing a framework of care for opioid medication misuse in community pharmacy.

Authors:  Gerald Cochran; Adam J Gordon; Craig Field; Jennifer Bacci; Ranjita Dhital; Thomas Ylioja; Maxine Stitzer; Thomas Kelly; Ralph Tarter
Journal:  Res Social Adm Pharm       Date:  2015-05-08

8.  Prescription opioid use: Patient characteristics and misuse in community pharmacy.

Authors:  Gerald Cochran; Jennifer L Bacci; Thomas Ylioja; Valerie Hruschak; Sharon Miller; Amy L Seybert; Ralph Tarter
Journal:  J Am Pharm Assoc (2003)       Date:  2016-03-24

9.  Psychosocial risks of prescription drug misuse among U.S. racial/ethnic minorities: A systematic review.

Authors:  Bridgette J Peteet
Journal:  J Ethn Subst Abuse       Date:  2017-11-27       Impact factor: 1.507

10.  Opioid-related overdose deaths among African Americans: Implications for research, practice and policy.

Authors:  Danelle Stevens-Watkins
Journal:  Drug Alcohol Rev       Date:  2020-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.